FLUOTREX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fluotrex, and what generic alternatives are available?
Fluotrex is a drug marketed by Savage Labs and is included in four NDAs.
The generic ingredient in FLUOTREX is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluotrex
A generic version of FLUOTREX was approved as fluocinolone acetonide by TARO on April 27th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUOTREX?
- What are the global sales for FLUOTREX?
- What is Average Wholesale Price for FLUOTREX?
Summary for FLUOTREX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| Patent Applications: | 4,334 |
| DailyMed Link: | FLUOTREX at DailyMed |
US Patents and Regulatory Information for FLUOTREX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Savage Labs | FLUOTREX | fluocinolone acetonide | CREAM;TOPICAL | 088174-001 | May 6, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Savage Labs | FLUOTREX | fluocinolone acetonide | SOLUTION;TOPICAL | 088171-001 | Mar 9, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Savage Labs | FLUOTREX | fluocinolone acetonide | CREAM;TOPICAL | 088173-001 | Mar 9, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Savage Labs | FLUOTREX | fluocinolone acetonide | OINTMENT;TOPICAL | 088172-001 | Mar 9, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
